{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:02:35Z","timestamp":1784354555396,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572619"],"award-info":[{"award-number":["81572619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-02918-4","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T20:02:30Z","timestamp":1661371350000},"page":"2453-2465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["TNFAIP3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion"],"prefix":"10.1007","volume":"24","author":[{"given":"Mengdi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WanRu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1533-0761","authenticated-orcid":false,"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"issue":"5","key":"2918_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RJC. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"2918_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fphar.2017.00963","volume":"8","author":"Q Li","year":"2017","unstructured":"Li Q, Kan X, Yin J, et al. Chamaejasmine B induces the anergy of vascular endothelial cells to VEGFA pro-angiogenic signal by autophagic regulation of VEGFR2 in breast cancer. Front Pharmacol. 2017;8:963.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2918_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-12-0362","volume":"3","author":"M Dieci","year":"2013","unstructured":"Dieci M, Arnedos M, Andre F, et al. Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives. Cancer Discov. 2013;3(3):264\u201379.","journal-title":"Cancer Discov"},{"issue":"12","key":"2918_CR4","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1681\/ASN.V11122199","volume":"11","author":"U Messmer","year":"2000","unstructured":"Messmer U, Briner V, Pfeilschifter J. Basic fibroblast growth factor selectively enhances TNF-\u03b1-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol. 2000;11(12):2199\u2013211.","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"2918_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104063","volume":"39","author":"S Wu","year":"2020","unstructured":"Wu S, Roden D, Wang C, et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J. 2020;39(19): e104063.","journal-title":"EMBO J"},{"issue":"6","key":"2918_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41401-018-0191-7","volume":"40","author":"Z Chen","year":"2019","unstructured":"Chen Z, Tong L, Tang B, et al. C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis. Acta Pharmacol Sin. 2019;40(6):823\u201332.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"2918_CR7","first-page":"2085","volume":"70","author":"N Turner","year":"2010","unstructured":"Turner N, Pearson A, Sharpe R, et al. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Expert Rev Anticancer Ther. 2010;70(5):2085\u201394.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2918_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1756-9966-31-103","volume":"31","author":"E Brunello","year":"2012","unstructured":"Brunello E, Brunelli M, Bogina G, et al. FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. J Exp Clin Cancer Res. 2012;31:103.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2918_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/CS20140390","volume":"129","author":"H Tzeng","year":"2015","unstructured":"Tzeng H, Chen P, Lin K, et al. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis. Clin Sci (Lond). 2015;129(2):147\u201358.","journal-title":"Clin Sci (Lond)"},{"issue":"24","key":"2918_CR10","doi-asserted-by":"publisher","first-page":"14339","DOI":"10.1111\/jcmm.16051","volume":"24","author":"Q Wu","year":"2020","unstructured":"Wu Q, Han L, Gui W, et al. MiR-503 suppresses fibroblast activation and myofibroblast differentiation by targeting VEGFA and FGFR1 in silica-induced pulmonary fibrosis. J Cell Mol Med. 2020;24(24):14339\u201348.","journal-title":"J Cell Mol Med"},{"issue":"7000","key":"2918_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"I Wertz","year":"2004","unstructured":"Wertz I, O\u2019rourke K, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-\u03baB signalling. Nature. 2004;430(7000):694\u20139.","journal-title":"Nature"},{"key":"2918_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.04.002","volume":"340","author":"B Malynn","year":"2019","unstructured":"Malynn B, et al. A20: a multifunctional tool for regulating immunity and preventing disease. Cell Immunol. 2019;340: 103914.","journal-title":"Cell Immunol"},{"issue":"1","key":"2918_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/BJ20071399","volume":"409","author":"D Komander","year":"2008","unstructured":"Komander D, et al. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J. 2008;409(1):77\u201385.","journal-title":"Biochem J"},{"issue":"2","key":"2918_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jmb.2007.11.092","volume":"376","author":"S Lin","year":"2008","unstructured":"Lin S, Chung J, Lamothe B, et al. Molecular basis for the unique deubiquitinating activity of the NF-\u03baB inhibitor A20. J Mol Biol. 2008;376(2):526\u201340.","journal-title":"J Mol Biol"},{"issue":"7","key":"2918_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/jcmm.12816","volume":"20","author":"J Li","year":"2016","unstructured":"Li J, Zhang L, Zhang Y, et al. A20 deficiency leads to angiogenesis of pulmonary artery endothelial cells through stronger NF-\u03baB activation under hypoxia. J Cell Mol Med. 2016;20(7):1319\u201328.","journal-title":"J Cell Mol Med"},{"issue":"15","key":"2918_CR16","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/j.yexcr.2006.05.015","volume":"312","author":"H Chng","year":"2006","unstructured":"Chng H, Camplejohn R, Stone M, et al. A new role for the anti-apoptotic gene A20 in angiogenesis. Exp Cell Res. 2006;312(15):2897\u2013907.","journal-title":"Exp Cell Res"},{"issue":"1","key":"2918_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13058-018-1024-9","volume":"20","author":"M Yang","year":"2018","unstructured":"Yang M, Yu X, Li X, et al. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells. Breast Cancer Res. 2018;20(1):97.","journal-title":"Breast Cancer Res"},{"issue":"14","key":"2918_CR18","first-page":"1185","volume":"92","author":"F Miller","year":"2000","unstructured":"Miller F, Santner S, Tait L, et al. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. Oncotarget. 2000;92(14):1185\u20136.","journal-title":"Oncotarget"},{"issue":"7347","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RJN. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298\u2013307.","journal-title":"Nature"},{"issue":"1","key":"2918_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner N, Semple J, Welch W, et al. Tumor angiogenesis and metastasis\u2013correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"2918_CR21","first-page":"830","volume":"16","author":"H Liu","year":"2018","unstructured":"Liu H, Tang L, Li X, et al. Triptolide inhibits vascular endothelial growth factor-mediated angiogenesis in human breast cancer cells. Exp Ther Med. 2018;16(2):830\u20136.","journal-title":"Exp Ther Med"},{"issue":"1","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","volume":"38","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Lu S, Li T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J Exp Clin Cancer Res. 2019;38(1):173.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2918_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/biomedicines10010117","volume":"10","author":"P Sung","year":"2022","unstructured":"Sung P, Yin T, Chai H, et al. Extracorporeal shock wave therapy salvages critical limb ischemia in B6 mice through upregulating cell proliferation signaling and angiogenesis. Biomedicines. 2022;10(1):117.","journal-title":"Biomedicines"},{"issue":"6","key":"2918_CR24","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.3390\/ijms23063375","volume":"23","author":"D Dakowicz","year":"2022","unstructured":"Dakowicz D, Zajkowska M, et al. Relationship between VEGF family members, their receptors and cell death in the neoplastic transformation of colorectal cancer. Int J Mol Sci. 2022;23(6):3375.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2918_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s13287-021-02649-3","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Tang L, Zhang F, et al. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia\/reperfusion injury via TRPC6-induced angiogenesis. Stem Cell Res Ther. 2021;12(1):584.","journal-title":"Stem Cell Res Ther"},{"key":"2918_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phrs.2018.04.021","volume":"133","author":"A Khwairakpam","year":"2018","unstructured":"Khwairakpam A, Bordoloi D, Thakur K, et al. Possible use of Punica granatum (Pomegranate) in cancer therapy. Pharmacol Res. 2018;133:53\u201364.","journal-title":"Pharmacol Res"},{"issue":"13","key":"2918_CR27","doi-asserted-by":"publisher","first-page":"17220","DOI":"10.18632\/oncotarget.7948","volume":"7","author":"H Peng","year":"2016","unstructured":"Peng H, Zhang Q, Li J, et al. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. Oncotarget. 2016;7(13):17220\u20139.","journal-title":"Oncotarget"},{"issue":"3","key":"2918_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","volume":"65","author":"T Tammela","year":"2005","unstructured":"Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65(3):550\u201363.","journal-title":"Cardiovasc Res"},{"issue":"24","key":"2918_CR29","doi-asserted-by":"publisher","first-page":"15099","DOI":"10.1074\/jbc.273.24.15099","volume":"273","author":"C Kevil","year":"1998","unstructured":"Kevil C, Payne D, Mire E, et al. Vascular permeability factor\/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem. 1998;273(24):15099\u2013103.","journal-title":"J Biol Chem"},{"issue":"6","key":"2918_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1096\/fj.02-0484fje","volume":"17","author":"M Behzadian","year":"2003","unstructured":"Behzadian M, Windsor L, Ghaly N, et al. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 2003;17(6):752\u20134.","journal-title":"FASEB J"},{"issue":"17","key":"2918_CR31","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1158\/0008-5472.CAN-18-3934","volume":"79","author":"A Pedrosa","year":"2019","unstructured":"Pedrosa A, Bodrug N, Gomez-Escudero J, et al. Tumor angiogenesis is differentially regulated by phosphorylation of endothelial cell focal adhesion kinase tyrosines-397 and -861. Cancer Res. 2019;79(17):4371\u201386.","journal-title":"Cancer Res"},{"issue":"6","key":"2918_CR32","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/S0002-9440(10)64325-8","volume":"162","author":"R Giavazzi","year":"2003","unstructured":"Giavazzi R, Sennino B, Coltrini D, et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol. 2003;162(6):1913\u201326.","journal-title":"Am J Pathol"},{"key":"2918_CR33","first-page":"1","volume":"237","author":"N Ferrara","year":"1999","unstructured":"Ferrara N, et al. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol. 1999;237:1\u201330.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"2918_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/atm-21-6499","volume":"10","author":"Z Xie","year":"2022","unstructured":"Xie Z, Chen J, Xiao Z, et al. TNFAIP3 alleviates pain in lumbar disc herniation rats by inhibiting the NF-\u03baB pathway. Ann Transl Med. 2022;10(2):80.","journal-title":"Ann Transl Med"},{"key":"2918_CR35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211083","author":"J Li","year":"2022","unstructured":"Li J, Kumari T, Barazia A, et al. Neutrophil DREAM promotes neutrophil recruitment in vascular inflammation. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20211083.","journal-title":"J Exp Med"},{"issue":"7","key":"2918_CR36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/art.1780390703","volume":"39","author":"E Paleolog","year":"1996","unstructured":"Paleolog E, Hunt M, Elliott M, et al. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum. 1996;39(7):1082\u201391.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2918_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2003.08.029","volume":"206","author":"F Greten","year":"2004","unstructured":"Greten F, Karin MJCL. The IKK\/NF-\u03baB activation pathway-a target for prevention and treatment of cancer. Cancer Lett. 2004;206(2):193\u20139.","journal-title":"Cancer Lett"},{"issue":"3","key":"2918_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12013-012-9509-0","volume":"66","author":"G Gu","year":"2013","unstructured":"Gu G, Zhang Y, Guo LJCB, et al. Ubiquitin E3 ligase A20 is required in degradation of microbial superantigens in vascular endothelial cells. Cell Biochem Biophys. 2013;66(3):649\u201355.","journal-title":"Cell Biochem Biophys"},{"issue":"10","key":"2918_CR39","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/onc.2012.145","volume":"32","author":"S Sakakibara","year":"2013","unstructured":"Sakakibara S, Espigol-Frigole G, Gasperini P, et al. A20\/TNFAIP3 inhibits NF-\u03baB activation induced by the Kaposi\u2019s sarcoma-associated herpesvirus vFLIP oncoprotein. Oncogene. 2013;32(10):1223\u201332.","journal-title":"Oncogene"},{"key":"2918_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.832215","volume":"13","author":"X Luo","year":"2022","unstructured":"Luo X, Liu Q, Zhou Z, et al. Cost-effectiveness of bevacizumab biosimilar LY01008 combined with chemotherapy as first-line treatment for Chinese patients with advanced or recurrent nonsquamous non-small cell lung cancer. Front Pharmacol. 2022;13: 832215.","journal-title":"Front Pharmacol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02918-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02918-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02918-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T17:11:10Z","timestamp":1665767470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02918-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02918-4","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}